European Federation of Biotechnology
Acronym: EFB
General Information
Identification Code: 835147046873-52
Website: [object Object]
Entity Form: AISBL charity registered in Belgium, but operating from an Office in Barcelonaa
Registration Category: Non-governmental organisations, platforms and networks and similar
Registration Date: 6/13/2022
Last Update: 6/12/2024
EP Accredited Number: 0
Mission & Interests
Goals: The European Federation of Biotechnology (EFB) is Europe’s non-profit federation of National Biotechnology Associations, Learned Societies, Universities, Scientific Institutes, Biotech Companies and individual biotechnologists working to promote biotechnology throughout Europe and beyond. As an independent “Voice of Biotechnology in Europe”, EFB promotes the safe, sustainable and beneficial use of fundamental research and innovation in life sciences, while providing a forum for interdisciplinary and international cooperation.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Agriculture and rural development
- Business and industry
- Climate action
- Communication
- Competition
- Consumers
- Culture
- Digital economy and society
- Economy, finance and the euro
- Education and training
- Employment and social affairs
- Energy
- Enlargement
- Environment
- European neighbourhood policy
- External relations
- Food safety
- Institutional affairs
- International co-operation and development
- Justice and fundamental rights
- Maritime affairs and fisheries
- Public health
- Regional policy
- Research and innovation
- Single market
- Trade
- Trans-European Networks
- Youth
Levels of Interest:
- global
Activities
Main EU Legislative Proposals: New genetic technologies: the need for a major revision of current EU regulations based upon scientific evidence regarding safety, sustainability and compatibility with EU objective such as those in the "Farm to Fork" policies and the response to climate change and global warming.
Debates on how to achieve a circular bioeconomy based upon sound science.
Communication Activities: Hjort, Cole and Frebort (2021) European genome editing regulations: threats to the European bioeconomy and unfit for purpose. EFB Bioeconomy Journal volume 1; November 2021; 100001. https://doi.org/10.1016/j.bioeco.2021.100001
Inter-institutional or Unofficial Groupings: Competitive European Industry: long-term and sustainable investment,SME
Head Office
Address: European Federation of BiotechnologyGran Via Carlos III, 98
Post Code: 08028
City: Barcelona
Country: SPAIN
Phone: [object Object]
EU Office
Address: European Federation of BiotechnologyGran Via Carlos III, 98
Post Code: 08028
City: Barcelona
Country: SPAIN
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Complementary Information: Individual members are supported by EU grants, but it is the policy of the European Federation of Biotechnology not to apply for or be involved in EU project funding.
Membership Information
Members10 Percent: 8
Members25 Percent: 0
Members50 Percent: 0
Members75 Percent: 0
Members: 8
Members F T E: 0.800000011920929
Info Members: Members of the Executive Board mainly work in academia, but the Board also includes three elected members from industry. We are emphatically not a lobby for any industrial sector, but promote policies based solely on sound scientific and economic evidence.
Structure
Structure Type: Structure
Is Member Of: For comprehensive list of EFB Institutional Members, see: http://www.efbiotechnology.org/sections/membership
Organisation Members: The EFB includes 35 organisation that support us as Institutional members. Many of them are national biotechnology societies plus a few supporting companies such as Novozymes, Astra-Zeneca, Eppendorf, Lonza.